SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Pamina who wrote (1275)9/19/1999 12:06:00 PM
From: Mephisto  Read Replies (1) | Respond to of 1580
 
I don't understand why JNJ won't split their stock. In the past it split around $100. If they would split, I believe it would attract more buyers.

Maybe we should e-mail the company and voice our complaints.



To: Pamina who wrote (1275)9/19/1999 1:56:00 PM
From: EyeDrMike  Read Replies (1) | Respond to of 1580
 
I think you may want to pull MCD and JNJ off the "dogs" and "ho hums" lists.

MCD has gone from 26 to 44 over the past 12 months, and JNJ has gone from 72 to 100+ over the same period. Very respectable returns relative to the DOW performance.

Look for JNJ to split by end of year. It just recently broke 100, and i would expect management already has a split announcement in the works.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News